Press release
Intravenous Immunoglobulin Market: Harnessing Growth Through Advancements in Plasma Fractionation & Rising Geriatric Population
Intravenous Immunoglobulin Market
The surging demand for better treatment methods for primary immunodeficiency disorders, neurological diseases, pediatric disorders, and other applications continues to fuel the expansion of the intravenous immunoglobulin market.
What Is The Projected Market Size Of The Global Intravenous Immunoglobulin Market And Its Growth Rate?
• The market is expected to grow from $14.66 billion in 2024 to $15.72 billion in 2025, emphasizing a CAGR of 7.2%.
• The rise of the intravenous immunoglobulin market over the years is credited to developments in plasma fractionation techniques, management of neurological disorders, increasing elderly population, and treatment for primary immunodeficiency disorders.
• By 2029, the market is poised to reach $22.01 billion, underpinned by a CAGR of 8.8%. The growth can be attributed to several factors such as ongoing immunology research, advancements in immunoglobulin products, a surge in healthcare expenditure, and the burgeoning incidence of autoimmune disorders and cancer.
What Is Driving The Growth In The Intravenous Immunoglobulin Market?
The rising geriatric population is a significant contributor to the growing demand for intravenous immunoglobulin. People above the age of 65 often experience a drop in immunity, leading to a pronounced need for antibodies supplied by immunoglobulins. To illustrate, projections by the Population Reference Bureau suggest a 47% increase in the population of Americans aged 65 and over, from 58 million in 2022 to 82 million by 2050. As the geriatric population's share climbs to 23% from the current 17% by 2050, the increasing need for intravenous immunoglobulin to supplement reduced immunity among the elderly will visibly drive the market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp
Who Are the Key Players Driving Intravenous Immunoglobulin Market Growth?
The key players propelling the market growth include:
• Bio Products Laboratory Limited
• Biotest AG
• China Biologic Products Holdings Inc.
• CSL Behring
• Grifols S.A.
• Kedrion Spa
• Shanghai RAAS Blood Products Co. Ltd.
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.
What Are The Key Trends In The Intravenous Immunoglobulin Market?
Trends playing a role in shaping the market:
• Treatment of primary immunodeficiency disorders (PIDD)
• Rapid innovations in technology
• Partnerships and collaborations in strategic planning
• Advances in manufacturing processes
• Applications in neurology and hematology
• Innovations in immunotherapy.
What Are The Segments Of The Global Intravenous Immunoglobulin Market?
The global market is categorized as per:
1) Type: IgG, IgM, IgA, IgE, IgD
2) Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) Application: Hypogammaglobulinemia, CIDP, Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) End-User: Hospitals, Clinics, Home Care
Which Region Leads The Intravenous Immunoglobulin Market?
North America dominated the intravenous immunoglobulin market in 2024, with the Asia-Pacific region following closely as the fastest-growing region in the forecast period. The market scope encompasses regions such as the Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
What Is Covered In The Intravenous Immunoglobulin Market Global Market Report?
- Market Size Analysis: Analyze the Intravenous Immunoglobulin Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Intravenous Immunoglobulin Market for effective categorization.
- Key Player Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Intravenous Immunoglobulin Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Intravenous Immunoglobulin Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=8538&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market: Harnessing Growth Through Advancements in Plasma Fractionation & Rising Geriatric Population here
News-ID: 3824884 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Intravenous
Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward…
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market
Soliris Intravenous Market Overview:
The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as…
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031
Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Key Finding
The global Intravenous (IV) Solution market and is expected to reach USD…
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is…
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075
Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness…
